You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Using pilot data from the GenomeAsia 100K Consortium, researchers searched for long, diverged haplotypes indicative of admixture between modern and archaic humans.
A CFTR gene mutation found in 90 percent of US cystic fibrosis patients was only present in a third of Puerto Rican and 10 percent of Dominican patients.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
At ASHG, researchers showed why they're moving away from limited, linear human reference genome representations and towards a more inclusive future.
OncoCyte provided additional details about the history of the Razor test, its timeline for making it commercially available, and plans for a follow-on study.
Winners of this year's Breakthrough Prize in the life sciences include researchers who studied neurodegenerative disorders and protein folding.
Researchers uncovered a variant in the β1-adrenergic receptor gene that appears to influence how much sleep someone needs, the New York Times reports.
The $10 million initiative will include scientists from the University of California's campuses, as well as from governmental and nongovernmental organizations.
The researchers identified genes that specifically extend the lifespan of neurons and found genes that increase the number of neurites in the brain.
The New York Times writes that genes may influence when people prefer to sleep.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.